Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with Chemotherapy

The standard treatment for colorectal mucosa-associated lymphoid tissue (MALT) lymphoma has not yet been established due to the rarity of the disease. Here, we report a case of long-term response to chemotherapy for colorectal MALT lymphoma (stage I). A 77-year-old frail female patient with diabetes...

Full description

Bibliographic Details
Main Authors: Makoto Saito, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Akio Mori, Masanobu Morioka, Takeshi Kondo, Hirokazu Sugino
Format: Article
Language:English
Published: Karger Publishers 2021-12-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://www.karger.com/Article/FullText/520428
_version_ 1819229235964805120
author Makoto Saito
Shihori Tsukamoto
Takashi Ishio
Emi Yokoyama
Koh Izumiyama
Akio Mori
Masanobu Morioka
Takeshi Kondo
Hirokazu Sugino
author_facet Makoto Saito
Shihori Tsukamoto
Takashi Ishio
Emi Yokoyama
Koh Izumiyama
Akio Mori
Masanobu Morioka
Takeshi Kondo
Hirokazu Sugino
author_sort Makoto Saito
collection DOAJ
description The standard treatment for colorectal mucosa-associated lymphoid tissue (MALT) lymphoma has not yet been established due to the rarity of the disease. Here, we report a case of long-term response to chemotherapy for colorectal MALT lymphoma (stage I). A 77-year-old frail female patient with diabetes mellitus and dementia developed melena of unknown etiology, and a colonoscopy was performed at a nearby hospital. A biopsy suggested malignant lymphoma, and she was referred to our department. As a result of re-examination of colonoscopy, a total of 3 submucosal tumor-like lesions were confirmed. Of these, a biopsy of the lesions in the ascending colon and rectum was performed, and MALT lymphoma was diagnosed on the basis of the histopathological findings. Following close examination, no other lymphoma lesions were found, and the patient was diagnosed with primary colorectal MALT lymphoma, stage I. After 1 course of R-THP-COP chemotherapy (rituximab + cyclophosphamide, pirarubicin, vincristine, and prednisone), the rectal lesion was confirmed to have almost disappeared endoscopically, and lymphoma cells were not found histopathologically. The patient was determined to be in complete remission (CR). However, due to hematological toxicity and a slight worsening of glucose control, the second chemotherapy course was changed to the BR regimen (rituximab + bendamustine), and 4 courses were performed (5 total courses of chemotherapy). Currently, >3 years have passed since reaching CR, and the patient is alive without recurrence.
first_indexed 2024-12-23T11:09:57Z
format Article
id doaj.art-17cd77d4527948d98ff948ab912c3e6e
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-12-23T11:09:57Z
publishDate 2021-12-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-17cd77d4527948d98ff948ab912c3e6e2022-12-21T17:49:22ZengKarger PublishersCase Reports in Oncology1662-65752021-12-011431761176710.1159/000520428520428Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with ChemotherapyMakoto Saito0https://orcid.org/0000-0002-2683-9475Shihori Tsukamoto1Takashi Ishio2Emi Yokoyama3Koh Izumiyama4Akio Mori5Masanobu Morioka6Takeshi Kondo7Hirokazu Sugino8Department of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Internal Medicine and Hematology/Blood Disorders Center, Aiiku Hospital, Sapporo, JapanDepartment of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, JapanThe standard treatment for colorectal mucosa-associated lymphoid tissue (MALT) lymphoma has not yet been established due to the rarity of the disease. Here, we report a case of long-term response to chemotherapy for colorectal MALT lymphoma (stage I). A 77-year-old frail female patient with diabetes mellitus and dementia developed melena of unknown etiology, and a colonoscopy was performed at a nearby hospital. A biopsy suggested malignant lymphoma, and she was referred to our department. As a result of re-examination of colonoscopy, a total of 3 submucosal tumor-like lesions were confirmed. Of these, a biopsy of the lesions in the ascending colon and rectum was performed, and MALT lymphoma was diagnosed on the basis of the histopathological findings. Following close examination, no other lymphoma lesions were found, and the patient was diagnosed with primary colorectal MALT lymphoma, stage I. After 1 course of R-THP-COP chemotherapy (rituximab + cyclophosphamide, pirarubicin, vincristine, and prednisone), the rectal lesion was confirmed to have almost disappeared endoscopically, and lymphoma cells were not found histopathologically. The patient was determined to be in complete remission (CR). However, due to hematological toxicity and a slight worsening of glucose control, the second chemotherapy course was changed to the BR regimen (rituximab + bendamustine), and 4 courses were performed (5 total courses of chemotherapy). Currently, >3 years have passed since reaching CR, and the patient is alive without recurrence.https://www.karger.com/Article/FullText/520428colorectal lymphomamucosa-associated lymphoid tissue lymphomatreatmentchemotherapy
spellingShingle Makoto Saito
Shihori Tsukamoto
Takashi Ishio
Emi Yokoyama
Koh Izumiyama
Akio Mori
Masanobu Morioka
Takeshi Kondo
Hirokazu Sugino
Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with Chemotherapy
Case Reports in Oncology
colorectal lymphoma
mucosa-associated lymphoid tissue lymphoma
treatment
chemotherapy
title Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with Chemotherapy
title_full Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with Chemotherapy
title_fullStr Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with Chemotherapy
title_full_unstemmed Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with Chemotherapy
title_short Multiple Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Successfully Treated with Chemotherapy
title_sort multiple colorectal mucosa associated lymphoid tissue lymphoma successfully treated with chemotherapy
topic colorectal lymphoma
mucosa-associated lymphoid tissue lymphoma
treatment
chemotherapy
url https://www.karger.com/Article/FullText/520428
work_keys_str_mv AT makotosaito multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT shihoritsukamoto multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT takashiishio multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT emiyokoyama multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT kohizumiyama multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT akiomori multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT masanobumorioka multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT takeshikondo multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy
AT hirokazusugino multiplecolorectalmucosaassociatedlymphoidtissuelymphomasuccessfullytreatedwithchemotherapy